C5 and colitis: Reports of a pathogenic role for C5a in colitis models are supported by the amelioration of disease pathology in mice and rats using C5aR deficient animals (Johswich et al., 2009), C5a blockade (Chen et al., 2011) or treatment with C5a agonists (Woodruff et al., 2003).